EcoR1 Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-963,333
| Closed | -$8.63M | – | 38 |
|
|
2025
Q4 | $8.63M | Hold |
963,333
| – | – | 0.39% | 24 |
|
|
2025
Q3 | $3.56M | Hold |
963,333
| – | – | 0.17% | 27 |
|
|
2025
Q2 | $1.88M | Hold |
963,333
| – | – | 0.11% | 36 |
|
|
2025
Q1 | $1.7M | Hold |
963,333
| – | – | 0.1% | 36 |
|
|
2024
Q4 | $2.56M | Hold |
963,333
| – | – | 0.1% | 50 |
|
|
2024
Q3 | $2.21M | Hold |
963,333
| – | – | 0.08% | 56 |
|
|
2024
Q2 | $2.81M | Hold |
963,333
| – | – | 0.09% | 52 |
|
|
2024
Q1 | $3.51M | Hold |
963,333
| – | – | 0.09% | 53 |
|
|
2023
Q4 | $1.45M | Hold |
963,333
| – | – | 0.04% | 48 |
|
|
2023
Q3 | $1.29M | Hold |
963,333
| – | – | 0.04% | 46 |
|
|
2023
Q2 | $1.73M | Hold |
963,333
| – | – | 0.04% | 46 |
|
|
2023
Q1 | $1.6M | Hold |
963,333
| – | – | 0.05% | 49 |
|
|
2022
Q4 | $1.85M | Hold |
963,333
| – | – | 0.06% | 57 |
|
|
2022
Q3 | $2.16M | Hold |
963,333
| – | – | 0.06% | 58 |
|
|
2022
Q2 | $3.12M | Hold |
963,333
| – | – | 0.11% | 54 |
|
|
2022
Q1 | $5.07M | Hold |
963,333
| – | – | 0.16% | 52 |
|
|
2021
Q4 | $8.19M | Hold |
963,333
| – | – | 0.26% | 42 |
|
|
2021
Q3 | $9.58M | Hold |
963,333
| – | – | 0.33% | 35 |
|
|
2021
Q2 | $8.97M | Hold |
963,333
| – | – | 0.34% | 36 |
|
|
2021
Q1 | $10.1M | Buy |
+963,333
| New | +$2.79M | 0.45% | 31 |
|
EcoR1 Capital's NUVB.WS Position: Q1 2026 in Review
EcoR1 Capital sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 963,333 shares — an estimated $8.63M sold.
EcoR1 Capital first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $10.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- EcoR1 Capital reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- EcoR1 Capital sold 963,333 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $8.63M.
- EcoR1 Capital first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
- EcoR1 Capital's Nuvation Bio Inc Warrants position peaked at $10.1M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on EcoR1 Capital's 13F filing for Q1 2026, filed 15 May 2026.